Marrone Bio Innovations Investor Relations Material
Latest events
Q1 2022
Marrone Bio Innovations
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Marrone Bio Innovations Inc
Access all reports
Marrone Bio Innovations, Inc. develops beneficial bacillus products for crop yield, quality, and performance. The company's products are manufactured from naturally occurring soil bacteria that have been used as microbial pesticides to control pests such as nematodes, insects, and mites. Its products include Regalia, Great Lakes BioSystems' proprietary plant-based bacillus formula for enhancing plant growth and controlling fungal disease; Grandevo, a biopesticide containing three different strains of beneficial bacilli for controlling insect pests and diseases; and Majestene, an insecticide containing various biopesticides to suppress nematode populations.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
MBII
Country
🇺🇸 United States